Lin- cells mediate tissue repair by regulating MCP-1/CCL-2

Area of Science:

• Regenerative Medicine
• Immunology
• Cell Biology

Background:

• Exogenous bone marrow-derived cells (BMDCs) show therapeutic potential for tissue ischemia and injury.
• Understanding the molecular mechanisms of BMDC action is crucial for developing effective therapies.
• BMDCs' rapid pro-healing effects suggest a role in modulating acute inflammation.

Purpose of the Study:

• To investigate the role of acute inflammation in mediating the therapeutic effects of BMDCs.
• To identify specific inflammatory mediators involved in BMDC-induced tissue repair.
• To determine if BMDC cytokine secretion can predict therapeutic efficacy.

Main Methods:

• Compared in vitro cytokine secretion and in vivo cytokine induction by BMDCs from healthy and obese, diabetic mice.
• Analyzed BMDC-treated ischemic limbs and cutaneous wounds in vivo.
• Assessed the role of monocyte chemoattractant factor 1 (MCF1) and tumor necrosis factor α (TNFα) in BMDC function.

Main Results:

• BMDCs from healthy, young mice stimulated vascular growth, unlike those from obese, diabetic mice.
• MCF1 and TNFα were identified as potential mediators of BMDC-induced tissue repair.
• MCF1 production by BMDCs was essential for vascular growth and healing in ischemic and wound models.
• The inability of BMDCs to produce TNFα had a lesser, but still significant, role.

Conclusions:

• MCF1 is a key mediator of BMDC-driven tissue repair and vascularization.
• Cytokine secretion profiles of BMDCs can predict their therapeutic potential.
• This finding may enable patient stratification for BMDC-based therapies.